Cell sheet approach for tissue engineering and regenerative medicine

Katsuhisa Matsuura, Rie Utoh, Kenichi Nagase, Teruo Okano

Research output: Contribution to journalReview article

112 Citations (Scopus)

Abstract

After the biotech medicine era, regenerative medicine is expected to be an advanced medicine that is capable of curing patients with difficult-to-treat diseases and physically impaired function. Our original scaffold-free cell sheet-based tissue engineering technology enables transplanted cells to be engrafted for a long time, while fully maintaining their viability. This technology has already been applied to various diseases in the clinical setting, including the cornea, esophagus, heart, periodontal ligament, and cartilage using autologous cells. Transplanted cell sheets not only replace the injured tissue and compensate for impaired function, but also deliver growth factors and cytokines in a spatiotemporal manner over a prolonged period, which leads to promotion of tissue repair. Moreover, the integration of stem cell biology and cell sheet technology with sufficient vascularization opens possibilities for fabrication of human three-dimensional vascularized dense and intact tissue grafts for regenerative medicine to parenchymal organs.

Original languageEnglish
Pages (from-to)228-239
Number of pages12
JournalJournal of Controlled Release
Volume190
DOIs
Publication statusPublished - 2014 Sep 28
Externally publishedYes

Fingerprint

Regenerative Medicine
Tissue Engineering
Technology
Medicine
Periodontal Ligament
Cornea
Esophagus
Cartilage
Cell Biology
Intercellular Signaling Peptides and Proteins
Stem Cells
Cytokines
Transplants

Keywords

  • Cell sheet
  • Regenerative medicine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Medicine(all)

Cite this

Cell sheet approach for tissue engineering and regenerative medicine. / Matsuura, Katsuhisa; Utoh, Rie; Nagase, Kenichi; Okano, Teruo.

In: Journal of Controlled Release, Vol. 190, 28.09.2014, p. 228-239.

Research output: Contribution to journalReview article

Matsuura, Katsuhisa ; Utoh, Rie ; Nagase, Kenichi ; Okano, Teruo. / Cell sheet approach for tissue engineering and regenerative medicine. In: Journal of Controlled Release. 2014 ; Vol. 190. pp. 228-239.
@article{93f5b3ed6d744cdc9893fd84b09e0665,
title = "Cell sheet approach for tissue engineering and regenerative medicine",
abstract = "After the biotech medicine era, regenerative medicine is expected to be an advanced medicine that is capable of curing patients with difficult-to-treat diseases and physically impaired function. Our original scaffold-free cell sheet-based tissue engineering technology enables transplanted cells to be engrafted for a long time, while fully maintaining their viability. This technology has already been applied to various diseases in the clinical setting, including the cornea, esophagus, heart, periodontal ligament, and cartilage using autologous cells. Transplanted cell sheets not only replace the injured tissue and compensate for impaired function, but also deliver growth factors and cytokines in a spatiotemporal manner over a prolonged period, which leads to promotion of tissue repair. Moreover, the integration of stem cell biology and cell sheet technology with sufficient vascularization opens possibilities for fabrication of human three-dimensional vascularized dense and intact tissue grafts for regenerative medicine to parenchymal organs.",
keywords = "Cell sheet, Regenerative medicine",
author = "Katsuhisa Matsuura and Rie Utoh and Kenichi Nagase and Teruo Okano",
year = "2014",
month = "9",
day = "28",
doi = "10.1016/j.jconrel.2014.05.024",
language = "English",
volume = "190",
pages = "228--239",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cell sheet approach for tissue engineering and regenerative medicine

AU - Matsuura, Katsuhisa

AU - Utoh, Rie

AU - Nagase, Kenichi

AU - Okano, Teruo

PY - 2014/9/28

Y1 - 2014/9/28

N2 - After the biotech medicine era, regenerative medicine is expected to be an advanced medicine that is capable of curing patients with difficult-to-treat diseases and physically impaired function. Our original scaffold-free cell sheet-based tissue engineering technology enables transplanted cells to be engrafted for a long time, while fully maintaining their viability. This technology has already been applied to various diseases in the clinical setting, including the cornea, esophagus, heart, periodontal ligament, and cartilage using autologous cells. Transplanted cell sheets not only replace the injured tissue and compensate for impaired function, but also deliver growth factors and cytokines in a spatiotemporal manner over a prolonged period, which leads to promotion of tissue repair. Moreover, the integration of stem cell biology and cell sheet technology with sufficient vascularization opens possibilities for fabrication of human three-dimensional vascularized dense and intact tissue grafts for regenerative medicine to parenchymal organs.

AB - After the biotech medicine era, regenerative medicine is expected to be an advanced medicine that is capable of curing patients with difficult-to-treat diseases and physically impaired function. Our original scaffold-free cell sheet-based tissue engineering technology enables transplanted cells to be engrafted for a long time, while fully maintaining their viability. This technology has already been applied to various diseases in the clinical setting, including the cornea, esophagus, heart, periodontal ligament, and cartilage using autologous cells. Transplanted cell sheets not only replace the injured tissue and compensate for impaired function, but also deliver growth factors and cytokines in a spatiotemporal manner over a prolonged period, which leads to promotion of tissue repair. Moreover, the integration of stem cell biology and cell sheet technology with sufficient vascularization opens possibilities for fabrication of human three-dimensional vascularized dense and intact tissue grafts for regenerative medicine to parenchymal organs.

KW - Cell sheet

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=84906783700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906783700&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2014.05.024

DO - 10.1016/j.jconrel.2014.05.024

M3 - Review article

C2 - 24858800

AN - SCOPUS:84906783700

VL - 190

SP - 228

EP - 239

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -